Protagonist Therapeutics
PTGX
PTGX
70 hedge funds and large institutions have $103M invested in Protagonist Therapeutics in 2018 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
+4
Holders Change %
+6.06%
% of All Funds
1.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
31
Reduced
15
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$9.31M |
| 2 |
BlackRock
New York
|
+$1.66M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$1.23M |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$1.17M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.14M |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$9.07M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$5.72M |
| 3 |
DM
Deerfield Management
New York
|
-$4.68M |
| 4 |
AIC
AWM Investment Company
New York
|
-$3.69M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.5M |
